These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3535251)

  • 1. Anti-HTLV III ELISA and Western blot testing in a blood donor population: implications for donor notification.
    Kleinman S; Anton-Guirigis H; Culver BD; Taylor TH; Prince HE; Kaplan HS
    Vox Sang; 1986; 51(2):143-7. PubMed ID: 3535251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis of the HTLV-III screening test for blood donors.
    Ellwein LB; Purtilo DT; Purtilo RB
    AIDS Res; 1986 Feb; 2(1):5-17. PubMed ID: 3013219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strip immunoblot for the confirmation of HTLV-I/II infection.
    Vrielink H; Zaaijer HL; Van der Poel CL; Quan S; Cuypers HT; Rios M; Lelie PN; Polito A; Sra K; DiNello R; Pichuantes S; Larson D; Reesink HW
    Vox Sang; 1996; 70(2):114-6. PubMed ID: 8801759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in ELISA verification of anti-HIV screening of blood donors.
    Hellings JA; Theunissen H; Keur W; Siebelink-Liauw A
    J Virol Methods; 1987 Aug; 17(1-2):11-7. PubMed ID: 3478345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV antibody screening and confirmatory testing of Italian blood donors. One-year experience of a reference center.
    Ferroni P; Tagger A; Pasquali M; Profeta ML
    Vox Sang; 1988; 55(3):143-7. PubMed ID: 3238947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic blood donor with a false positive HTLV-III Western blot.
    Saag MS; Britz J
    N Engl J Med; 1986 Jan; 314(2):118. PubMed ID: 3510382
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
    Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
    León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
    Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of HIV infection in recipients of untested blood from donors now anti-HIV-positive.
    Grindon AJ; Critchley SE; Ward JW
    Transfusion; 1988; 28(5):419-21. PubMed ID: 3047919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
    Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
    Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.
    Sayers MH; Beatty PG; Hansen JA
    Transfusion; 1986; 26(1):113-5. PubMed ID: 3003973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
    Zaaijer HL; Cuypers HT; Dudok de Wit C; Lelie PN
    Transfusion; 1994 Oct; 34(10):877-80. PubMed ID: 7940659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti LAV/HTLV III antibodies in blood donors: preliminary results of pool screening of 5 samples].
    el Khoury AB; Muller A; Richard D
    Rev Fr Transfus Immunohematol; 1986 Jun; 29(3):183-92. PubMed ID: 3466317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-III antibody testing in three Danish blood banks.
    Orskov Lindhardt B; Ulrich K; Ryder L; Dickmeiss E; Sørensen H; Jørgensen J; Jersild C; Grunnet N
    Vox Sang; 1986; 51 Suppl 1():9-14. PubMed ID: 3017006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.